Search Results - "Stathopoulos, George P"

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes by Stathopoulos, George P, Malamos, Nikolaos A, Markopoulos, Christos, Polychronis, Athanasios, Armakolas, Athanasios, Rigatos, Sotirios, Yannopoulou, Anna, Kaparelou, Maria, Antoniou, Photini

“…The Ki-67 antigen was identified in the early steps of polymerase I-dependent ribosomal RNA synthesis. Although it seems that this protein has an important…”
Get full text

Liposomal Oxaliplatin in the Treatment of Advanced Cancer: A Phase I Study by STATHOPOULOS, George P, BOULIKAS, Teni, KOURVETARIS, Andreas, STATHOPOULOS, John

“…Background: Lipoxal is a liposomal oxaliplatin, which reduces the cytotoxic agent's adverse reactions without reducing effectiveness. Our objectives were to…”
Get full text

Liposomal cisplatin: a new cisplatin formulation by Stathopoulos, George P

“…Over the last three decades, cisplatin has been one of the most effective cytotoxic agents, but its administration has been hindered by its nephrotoxicity,…”
Get full text

Decreased Plasma Ghrelin Levels in Patients with Advanced Cancer and Weight Loss in Comparison to Healthy Individuals by Legakis, Ioannis, Stathopoulos, John, Matzouridis, Timos, Stathopoulos, George P

“…Background: Ghrelin is a growth hormone-releasing acylated peptide found to be an appetite stimulant and low levels of it are detected in cachexia. The aim of…”
Get full text

Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes by Dueñas, Marta, Santos, Mirentxu, Aranda, Juan F, Bielza, Concha, Martínez-Cruz, Ana B, Lorz, Corina, Taron, Miquel, Ciruelos, Eva M, Rodríguez-Peralto, José L, Martín, Miguel, Larrañaga, Pedro, Dahabreh, Jubrail, Stathopoulos, George P, Rosell, Rafael, Paramio, Jesús M, García-Escudero, Ramón

“…Mutations in the TP53 gene are very common in human cancers, and are associated with poor clinical outcome. Transgenic mouse models lacking the Trp53 gene or…”
Get full text

Present Treatment and Future Expectations in Advanced Pancreatic Cancer by STATHOPOULOS, George P, ANDROULAKIS, Nikos, SOUGLAKOS, John, STATHOPOULOS, John, GEORGOULIAS, Vassilis

“…Advanced or metastatic pancreatic cancer is an incurable disease. The main treatment is chemotherapy with cytotoxic agents. On the basis of our experience in…”
Get full text

Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer by Trafalis, Dimitrios T., Alifieris, Constantinos, Stathopoulos, George P., Sitaras, Nikolaos

“…Purpose This phase II study investigates the efficacy and safety of DNA topoisomerase I inhibitor irinotecan plus bevacizumab a monoclonal antibody against…”
Get full text

Bone metastasis in breast cancer is treated by high-dose tamoxifen by Stathopoulos, George P, Trafalis, Dimitrios, Kaparelou, Maria

“…Bone metastases in breast cancer are quite common, and some patients may have no other site of metastasis. An effective treatment is often endocrine agents…”
Get more information

A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors by Alifieris, Constantinos E., Orfanakos, Kyriakos, Papanota, Aristina, Stathopoulos, George P., Sitaras, Nikolaos, Trafalis, Dimitrios T.

“…Purpose This is a single-center uncontrolled retrospective study to evaluate the efficacy and safety of the biosimilar epoetin zeta after approval in…”
Get full text

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial by Gogas, Helen, Dafni, Urania, Karina, Maria, Papadimitriou, Christos, Batistatou, Anna, Bobos, Mattheos, Kalofonos, Haralabos P., Eleftheraki, Anastasia G., Timotheadou, Eleni, Bafaloukos, Dimitrios, Christodoulou, Christos, Markopoulos, Christos, Briasoulis, Evangelos, Papakostas, Pavlos, Samantas, Epaminontas, Kosmidis, Paris, Stathopoulos, George P., Karanikiotis, Charisios, Pectasides, Dimitrios, Dimopoulos, Meletios A., Fountzilas, George

“…To explore the impact of dose intensity (DI) in the adjuvant setting of breast cancer, a randomized phase III trial was conducted comparing postoperative…”
Get full text

Therapeutic Administration of Pegfilgrastim Instead of Prophylactic Use by STATHOPOULOS, George P, DIMOU, Evangelini, STATHOPOULOS, John, XYNOTROULAS, John

“…Objectives: Pegfilgrastim is a new growth factor which can be administered subcutaneously once (versus multiple doses for days) on the day neutropenia occurs…”
Get full text

Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients by ARMAKOLAS, ATHANASIOS, STATHOPOULOS, GEORGE P, NEZOS, ADRIANOS, THEOS, APOSTOLOS, STATHAKI, MARTHA, KOUTSILIERIS, MICHAEL

“…Gene expression patterns as well as gene interactions are under investigation for their involvement in tumour heterogeneity. The molecular classification of…”
Get full text

Mesothelioma: Treatment and Survival of a Patient Population and Review of the Literature by STATHOPOULOS, John, ANTONIOU, Dimosthenis, STATHOPOULOS, George P, RIGATOS, Sotiris K, DIMITROULIS, John, KOUTANDOS, John, MICHALOPOULOU, Pinelopi, ATHANASIADES, Athanasios, VESLEMES, Marinos

“…Background: Our purpose was to evaluate the survival of patients with pleural and intraperitoneal malignant mesothelioma and, particularly, to estimate the…”
Get full text

Phase II Study of Cisplatin-combined Schedules as Second-line Chemotherapy in Patients with Non-Small Cell Lung Cancer by VESLEMES, Marinos, ANTONIOU, Dimosthenis, GEORGATOU, Niki, GIAMBOUDAKIS, Pantelis, DIMITROULIS, John, KATIS, Kostas, STATHOPOULOS, George P

“…Background: The aim of this study was to evaluate the effectiveness of cisplatin- (CDDP) combined chemotherapy in non-cisplatin pretreated patients with…”
Get full text

Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer by Antoniou, Dimosthenis, Pavlakou, Georgia, Stathopoulos, George P., Karydis, Ioannis, Chondrou, Evangelia, Papageorgiou, Chrysovalantis, Dariotaki, Fotini, Chaimala, Dimitra, Veslemes, Marinos

“…Patients with cancer may present with one or more circulatory markers of haemostatic activation which may be associated with tumor growth and cancer cell…”
Get full text

Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): phase I study by Stathopoulos, George P, Boulikas, Teni, Vougiouka, Maria, Deliconstantinos, George, Rigatos, Sotirios, Darli, Eleftheria, Viliotou, Vasiliki, Stathopoulos, John G

“…Lipoplatin, a new liposomal cisplatin formulation, is formed from cisplatin and liposomes composed of dipalmitoyl phosphatidyl glycerol (DPPG), soy…”
Get more information

A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer by Ignatiadis, Michail, Polyzos, Aris, Stathopoulos, George P, Tselepatiotis, Evangelos, Christophylakis, Charalambos, Kalbakis, Kostas, Vamvakas, Lambros, Kotsakis, Athanasios, Potamianou, Anna, Georgoulias, Vassilis

“…To evaluate the efficacy and tolerance of the docetaxel/gefitinib combination as second-line treatment in patients with advanced pancreatic cancer. Twenty-six…”
Get more information

Liposomal cisplatin combined with gemcitabine in pretreated advanced pancreatic cancer patients : A phase I-II study by STATHOPOULOS, George P, BOULIKAS, Teni, VOUGIOUKA, Maria, RIGATOS, Sotirios K, STATHOPOULOS, John G

“…The present trial is a phase I-II study based on a new liposomal cisplatin (lipoplatin). Previous preclinical and clinical data (phase I pharmacokinetics) led…”
Get full text

Pemetrexed combined with paclitaxel in patients with advanced or metastatic non-small-cell lung cancer: A phase I-II trial by Stathopoulos, George P, Dimitroulis, John, Toubis, Michael, Katis, Costas, Karaindros, Dimitris, Stathopoulos, John, Koutandos, John

“…Summary Pemetrexed, a novel multi-targeted agent established for the treatment of mesothelioma, has been under investigation for other malignancies, and in…”
Get full text

Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesothelioma by Trafalis, Dimitrios T, Alifieris, Constantinos, Krikelis, Dimitrios, Tzogkas, Nikolaos, Stathopoulos, George P, Athanassiou, Athanassios E, Sitaras, Nikolaos M

“…Malignant pleural mesothelioma (MPM) is an aggressive disease with poor or modest responses to chemotherapy and dismal prognosis. In most of the cases the…”
Get full text